Selected research
Industry Research
Antiviral Traditional Chinese Medicine Industry Research Report 2026
Market perspective
The global Antiviral Traditional Chinese Medicine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Antiviral Traditional Chinese Medicine market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Antiviral Traditional Chinese Medicine market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Antiviral Traditional Chinese Medicine market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Antiviral Traditional Chinese Medicine include Buchang Pharmaceutical, Guangzhou Pharmaceutical, Harbin Pharmaceutical Group, Harbin Pharmaceutical Group, Shineway Pharmaceutical, Fusen Pharmaceutical, Gerun Pharmaceutical, CR SANJIU and Jumpcan, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Antiviral Traditional Chinese Medicine market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Antiviral Traditional Chinese Medicine.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Antiviral Traditional Chinese Medicine Market by Company
Buchang Pharmaceutical
Guangzhou Pharmaceutical
Harbin Pharmaceutical Group
Harbin Pharmaceutical Group
Shineway Pharmaceutical
Fusen Pharmaceutical
Gerun Pharmaceutical
CR SANJIU
Jumpcan
Qingfeng Pharmaceutical Group
Livzon
Green Valley Pharma
Chase Sun Pharmaceutical
TASLY
Yusheng Pharmaceutical
Tongrentang
Wuzhou Pharmaceutical
Yiling Pharmaceutical
Yunnan Baiyao
Changbaishan Pharmaceutical
Zhejiang Conba Pharmaceutical
Zhejiang Kanglaite Pharmaceutical
ZBD Pharmaceutical
China TCM
Antiviral Traditional Chinese Medicine Segment by Type
Anti-herpes Virus
Anti-influenza Virus
Anti-HIV
Anti-HBV
Anti-CVB
Other
Antiviral Traditional Chinese Medicine Segment by Application
Adult
Children
Antiviral Traditional Chinese Medicine Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiviral Traditional Chinese Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Antiviral Traditional Chinese Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiviral Traditional Chinese Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Antiviral Traditional Chinese Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Antiviral Traditional Chinese Medicine Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Antiviral Traditional Chinese Medicine Revenue Market Share by Type (2021-2026)
Table 7. Global Antiviral Traditional Chinese Medicine Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Antiviral Traditional Chinese Medicine Revenue Market Share by Type (2027-2032)
Table 9. Global Antiviral Traditional Chinese Medicine Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Antiviral Traditional Chinese Medicine Revenue Market Share by Application (2021-2026)
Table 11. Global Antiviral Traditional Chinese Medicine Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Antiviral Traditional Chinese Medicine Revenue Market Share by Application (2027-2032)
Table 13. Global Antiviral Traditional Chinese Medicine Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Antiviral Traditional Chinese Medicine Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Antiviral Traditional Chinese Medicine Market Share by Region (2021-2026)
Table 16. Global Antiviral Traditional Chinese Medicine Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Antiviral Traditional Chinese Medicine Market Share by Region (2027-2032)
Table 18. Antiviral Traditional Chinese Medicine Industry Trends
Table 19. Antiviral Traditional Chinese Medicine Industry Drivers
Table 20. Antiviral Traditional Chinese Medicine Industry Opportunities and Challenges
Table 21. Antiviral Traditional Chinese Medicine Market Restraints
Table 22. Global Top Antiviral Traditional Chinese Medicine Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Antiviral Traditional Chinese Medicine Revenue Market Share by Players (2021-2026)
Table 24. Global Antiviral Traditional Chinese Medicine Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Antiviral Traditional Chinese Medicine, Headquarters and Area Served
Table 26. Global Antiviral Traditional Chinese Medicine Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Antiviral Traditional Chinese Medicine by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Antiviral Traditional Chinese Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Antiviral Traditional Chinese Medicine Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Antiviral Traditional Chinese Medicine Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Antiviral Traditional Chinese Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Antiviral Traditional Chinese Medicine Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Antiviral Traditional Chinese Medicine Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Antiviral Traditional Chinese Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Antiviral Traditional Chinese Medicine Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Antiviral Traditional Chinese Medicine Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Antiviral Traditional Chinese Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Antiviral Traditional Chinese Medicine Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Antiviral Traditional Chinese Medicine Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Antiviral Traditional Chinese Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Country (2027-2032) & (US$ Million)
Table 45. Buchang Pharmaceutical Company Information
Table 46. Buchang Pharmaceutical Business Overview
Table 47. Buchang Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 48. Buchang Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
Table 49. Buchang Pharmaceutical Recent Developments
Table 50. Guangzhou Pharmaceutical Company Information
Table 51. Guangzhou Pharmaceutical Business Overview
Table 52. Guangzhou Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 53. Guangzhou Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
Table 54. Guangzhou Pharmaceutical Recent Developments
Table 55. Harbin Pharmaceutical Group Company Information
Table 56. Harbin Pharmaceutical Group Business Overview
Table 57. Harbin Pharmaceutical Group Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 58. Harbin Pharmaceutical Group Antiviral Traditional Chinese Medicine Product Portfolio
Table 59. Harbin Pharmaceutical Group Recent Developments
Table 60. Harbin Pharmaceutical Group Company Information
Table 61. Harbin Pharmaceutical Group Business Overview
Table 62. Harbin Pharmaceutical Group Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 63. Harbin Pharmaceutical Group Antiviral Traditional Chinese Medicine Product Portfolio
Table 64. Harbin Pharmaceutical Group Recent Developments
Table 65. Shineway Pharmaceutical Company Information
Table 66. Shineway Pharmaceutical Business Overview
Table 67. Shineway Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 68. Shineway Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
Table 69. Shineway Pharmaceutical Recent Developments
Table 70. Fusen Pharmaceutical Company Information
Table 71. Fusen Pharmaceutical Business Overview
Table 72. Fusen Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 73. Fusen Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
Table 74. Fusen Pharmaceutical Recent Developments
Table 75. Gerun Pharmaceutical Company Information
Table 76. Gerun Pharmaceutical Business Overview
Table 77. Gerun Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 78. Gerun Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
Table 79. Gerun Pharmaceutical Recent Developments
Table 80. CR SANJIU Company Information
Table 81. CR SANJIU Business Overview
Table 82. CR SANJIU Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 83. CR SANJIU Antiviral Traditional Chinese Medicine Product Portfolio
Table 84. CR SANJIU Recent Developments
Table 85. Jumpcan Company Information
Table 86. Jumpcan Business Overview
Table 87. Jumpcan Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 88. Jumpcan Antiviral Traditional Chinese Medicine Product Portfolio
Table 89. Jumpcan Recent Developments
Table 90. Qingfeng Pharmaceutical Group Company Information
Table 91. Qingfeng Pharmaceutical Group Business Overview
Table 92. Qingfeng Pharmaceutical Group Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 93. Qingfeng Pharmaceutical Group Antiviral Traditional Chinese Medicine Product Portfolio
Table 94. Qingfeng Pharmaceutical Group Recent Developments
Table 95. Livzon Company Information
Table 96. Livzon Business Overview
Table 97. Livzon Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 98. Livzon Antiviral Traditional Chinese Medicine Product Portfolio
Table 99. Livzon Recent Developments
Table 100. Green Valley Pharma Company Information
Table 101. Green Valley Pharma Business Overview
Table 102. Green Valley Pharma Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 103. Green Valley Pharma Antiviral Traditional Chinese Medicine Product Portfolio
Table 104. Green Valley Pharma Recent Developments
Table 105. Chase Sun Pharmaceutical Company Information
Table 106. Chase Sun Pharmaceutical Business Overview
Table 107. Chase Sun Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 108. Chase Sun Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
Table 109. Chase Sun Pharmaceutical Recent Developments
Table 110. TASLY Company Information
Table 111. TASLY Business Overview
Table 112. TASLY Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 113. TASLY Antiviral Traditional Chinese Medicine Product Portfolio
Table 114. TASLY Recent Developments
Table 115. Yusheng Pharmaceutical Company Information
Table 116. Yusheng Pharmaceutical Business Overview
Table 117. Yusheng Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 118. Yusheng Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
Table 119. Yusheng Pharmaceutical Recent Developments
Table 120. Tongrentang Company Information
Table 121. Tongrentang Business Overview
Table 122. Tongrentang Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 123. Tongrentang Antiviral Traditional Chinese Medicine Product Portfolio
Table 124. Tongrentang Recent Developments
Table 125. Wuzhou Pharmaceutical Company Information
Table 126. Wuzhou Pharmaceutical Business Overview
Table 127. Wuzhou Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 128. Wuzhou Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
Table 129. Wuzhou Pharmaceutical Recent Developments
Table 130. Yiling Pharmaceutical Company Information
Table 131. Yiling Pharmaceutical Business Overview
Table 132. Yiling Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 133. Yiling Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
Table 134. Yiling Pharmaceutical Recent Developments
Table 135. Yunnan Baiyao Company Information
Table 136. Yunnan Baiyao Business Overview
Table 137. Yunnan Baiyao Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 138. Yunnan Baiyao Antiviral Traditional Chinese Medicine Product Portfolio
Table 139. Yunnan Baiyao Recent Developments
Table 140. Changbaishan Pharmaceutical Company Information
Table 141. Changbaishan Pharmaceutical Business Overview
Table 142. Changbaishan Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 143. Changbaishan Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
Table 144. Changbaishan Pharmaceutical Recent Developments
Table 145. Zhejiang Conba Pharmaceutical Company Information
Table 146. Zhejiang Conba Pharmaceutical Business Overview
Table 147. Zhejiang Conba Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 148. Zhejiang Conba Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
Table 149. Zhejiang Conba Pharmaceutical Recent Developments
Table 150. Zhejiang Kanglaite Pharmaceutical Company Information
Table 151. Zhejiang Kanglaite Pharmaceutical Business Overview
Table 152. Zhejiang Kanglaite Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 153. Zhejiang Kanglaite Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
Table 154. Zhejiang Kanglaite Pharmaceutical Recent Developments
Table 155. ZBD Pharmaceutical Company Information
Table 156. ZBD Pharmaceutical Business Overview
Table 157. ZBD Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 158. ZBD Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
Table 159. ZBD Pharmaceutical Recent Developments
Table 160. China TCM Company Information
Table 161. China TCM Business Overview
Table 162. China TCM Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026) & (US$ Million)
Table 163. China TCM Antiviral Traditional Chinese Medicine Product Portfolio
Table 164. China TCM Recent Developments
Table 165. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Antiviral Traditional Chinese Medicine Product Image
Figure 5. Global Antiviral Traditional Chinese Medicine Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Antiviral Traditional Chinese Medicine Market Share by Type: 2025 VS 2032
Figure 7. Anti-herpes Virus Product
Figure 8. Anti-influenza Virus Product
Figure 9. Anti-HIV Product
Figure 10. Anti-HBV Product
Figure 11. Anti-CVB Product
Figure 12. Other Product
Figure 13. Global Antiviral Traditional Chinese Medicine Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 14. Global Antiviral Traditional Chinese Medicine Market Share by Application: 2025 VS 2032
Figure 15. Adult Product
Figure 16. Children Product
Figure 17. Global Antiviral Traditional Chinese Medicine Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 18. Global Antiviral Traditional Chinese Medicine Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 19. Global Antiviral Traditional Chinese Medicine Market Share by Region: 2025 VS 2032
Figure 20. Global Antiviral Traditional Chinese Medicine Market Share by Players in 2025
Figure 21. Global Antiviral Traditional Chinese Medicine Manufacturers Established Date
Figure 22. Global Top 5 and 10 Antiviral Traditional Chinese Medicine Players Market Share by Revenue in 2025
Figure 23. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 24. North America Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. North America Antiviral Traditional Chinese Medicine Market Share by Country (2021-2032)
Figure 26. United States Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Canada Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 28. Mexico Antiviral Traditional Chinese Medicine Market Share by Country (2021-2032)
Figure 29. Europe Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. Europe Antiviral Traditional Chinese Medicine Market Share by Country (2021-2032)
Figure 31. Germany Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. France Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. U.K. Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Italy Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Spain Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Russia Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Netherlands Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 38. Nordic Countries Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Asia-Pacific Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. Asia-Pacific Antiviral Traditional Chinese Medicine Market Share by Country (2021-2032)
Figure 41. China Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. Japan Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 43. South Korea Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. India Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. India Antiviral Traditional Chinese Medicine Market Share by Country (2021-2032)
Figure 46. Australia Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. China Taiwan Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 48. Southeast Asia Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. South America Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. South America Antiviral Traditional Chinese Medicine Market Share by Country (2021-2032)
Figure 51. Brazil Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Argentina Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. Chile Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 54. Colombia Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 55. Peru Antiviral Traditional Chinese Medicine Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 56. Buchang Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 57. Guangzhou Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 58. Harbin Pharmaceutical Group Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 59. Harbin Pharmaceutical Group Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 60. Shineway Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 61. Fusen Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 62. Gerun Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 63. CR SANJIU Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 64. Jumpcan Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 65. Qingfeng Pharmaceutical Group Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 66. Livzon Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 67. Green Valley Pharma Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 68. Chase Sun Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 69. TASLY Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 70. Yusheng Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 71. Tongrentang Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 72. Wuzhou Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 73. Yiling Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 74. Yunnan Baiyao Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 75. Changbaishan Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 76. Zhejiang Conba Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 77. Zhejiang Kanglaite Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 78. ZBD Pharmaceutical Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Figure 79. China TCM Revenue Growth Rate in Antiviral Traditional Chinese Medicine Business (2021-2026)
Scope & coverage.
Types
- Anti-herpes Virus
- Anti-influenza Virus
- Anti-HIV
- Anti-HBV
- Anti-CVB
- Other
Applications
- Adult
- Children
Companies covered
- Buchang Pharmaceutical
- Guangzhou Pharmaceutical
- Harbin Pharmaceutical Group
- Harbin Pharmaceutical Group
- Shineway Pharmaceutical
- Fusen Pharmaceutical
- Gerun Pharmaceutical
- CR SANJIU
- Jumpcan
- Qingfeng Pharmaceutical Group
- Livzon
- Green Valley Pharma
- Chase Sun Pharmaceutical
- TASLY
- Yusheng Pharmaceutical
- Tongrentang
- Wuzhou Pharmaceutical
- Yiling Pharmaceutical
- Yunnan Baiyao
- Changbaishan Pharmaceutical
- Zhejiang Conba Pharmaceutical
- Zhejiang Kanglaite Pharmaceutical
- ZBD Pharmaceutical
- China TCM
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Antiviral Traditional Chinese Medicine by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Anti-herpes Virus
- 2.2.3 Anti-influenza Virus
- 2.2.4 Anti-HIV
- 2.2.5 Anti-HBV
- 2.2.6 Anti-CVB
- 2.2.7 Other
- 2.3 Antiviral Traditional Chinese Medicine by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Adult
- 2.3.3 Children
- 2.4 Assumptions and Limitations
3 Antiviral Traditional Chinese Medicine Breakdown Data by Type
- 3.1 Global Antiviral Traditional Chinese Medicine Historic Market Size by Type (2021-2026)
- 3.2 Global Antiviral Traditional Chinese Medicine Forecasted Market Size by Type (2027-2032)
4 Antiviral Traditional Chinese Medicine Breakdown Data by Application
- 4.1 Global Antiviral Traditional Chinese Medicine Historic Market Size by Application (2021-2026)
- 4.2 Global Antiviral Traditional Chinese Medicine Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Antiviral Traditional Chinese Medicine Market Perspective (2021-2032)
- 5.2 Global Antiviral Traditional Chinese Medicine Growth Trends by Region
- 5.2.1 Global Antiviral Traditional Chinese Medicine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Antiviral Traditional Chinese Medicine Historic Market Size by Region (2021-2026)
- 5.2.3 Antiviral Traditional Chinese Medicine Forecasted Market Size by Region (2027-2032)
- 5.3 Antiviral Traditional Chinese Medicine Market Dynamics
- 5.3.1 Antiviral Traditional Chinese Medicine Industry Trends
- 5.3.2 Antiviral Traditional Chinese Medicine Market Drivers
- 5.3.3 Antiviral Traditional Chinese Medicine Market Challenges
- 5.3.4 Antiviral Traditional Chinese Medicine Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Antiviral Traditional Chinese Medicine Players by Revenue
- 6.1.1 Global Top Antiviral Traditional Chinese Medicine Players by Revenue (2021-2026)
- 6.1.2 Global Antiviral Traditional Chinese Medicine Revenue Market Share by Players (2021-2026)
- 6.2 Global Antiviral Traditional Chinese Medicine Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Antiviral Traditional Chinese Medicine Head Office and Area Served
- 6.4 Global Antiviral Traditional Chinese Medicine Players, Product Type & Application
- 6.5 Global Antiviral Traditional Chinese Medicine Manufacturers Established Date
- 6.6 Global Antiviral Traditional Chinese Medicine Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Antiviral Traditional Chinese Medicine Market Size (2021-2032)
- 7.2 North America Antiviral Traditional Chinese Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Antiviral Traditional Chinese Medicine Market Size by Country (2021-2026)
- 7.4 North America Antiviral Traditional Chinese Medicine Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Antiviral Traditional Chinese Medicine Market Size (2021-2032)
- 8.2 Europe Antiviral Traditional Chinese Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Antiviral Traditional Chinese Medicine Market Size by Country (2021-2026)
- 8.4 Europe Antiviral Traditional Chinese Medicine Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Antiviral Traditional Chinese Medicine Market Size (2021-2032)
- 9.2 Asia-Pacific Antiviral Traditional Chinese Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Antiviral Traditional Chinese Medicine Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Antiviral Traditional Chinese Medicine Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Antiviral Traditional Chinese Medicine Market Size (2021-2032)
- 10.2 South America Antiviral Traditional Chinese Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Antiviral Traditional Chinese Medicine Market Size by Country (2021-2026)
- 10.4 South America Antiviral Traditional Chinese Medicine Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Antiviral Traditional Chinese Medicine Market Size (2021-2032)
- 11.2 Middle East & Africa Antiviral Traditional Chinese Medicine Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Antiviral Traditional Chinese Medicine Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Buchang Pharmaceutical
- 12.1.1 Buchang Pharmaceutical Company Information
- 12.1.2 Buchang Pharmaceutical Business Overview
- 12.1.3 Buchang Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.1.4 Buchang Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
- 12.1.5 Buchang Pharmaceutical Recent Developments
- 12.2 Guangzhou Pharmaceutical
- 12.2.1 Guangzhou Pharmaceutical Company Information
- 12.2.2 Guangzhou Pharmaceutical Business Overview
- 12.2.3 Guangzhou Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.2.4 Guangzhou Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
- 12.2.5 Guangzhou Pharmaceutical Recent Developments
- 12.3 Harbin Pharmaceutical Group
- 12.3.1 Harbin Pharmaceutical Group Company Information
- 12.3.2 Harbin Pharmaceutical Group Business Overview
- 12.3.3 Harbin Pharmaceutical Group Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.3.4 Harbin Pharmaceutical Group Antiviral Traditional Chinese Medicine Product Portfolio
- 12.3.5 Harbin Pharmaceutical Group Recent Developments
- 12.4 Harbin Pharmaceutical Group
- 12.4.1 Harbin Pharmaceutical Group Company Information
- 12.4.2 Harbin Pharmaceutical Group Business Overview
- 12.4.3 Harbin Pharmaceutical Group Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.4.4 Harbin Pharmaceutical Group Antiviral Traditional Chinese Medicine Product Portfolio
- 12.4.5 Harbin Pharmaceutical Group Recent Developments
- 12.5 Shineway Pharmaceutical
- 12.5.1 Shineway Pharmaceutical Company Information
- 12.5.2 Shineway Pharmaceutical Business Overview
- 12.5.3 Shineway Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.5.4 Shineway Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
- 12.5.5 Shineway Pharmaceutical Recent Developments
- 12.6 Fusen Pharmaceutical
- 12.6.1 Fusen Pharmaceutical Company Information
- 12.6.2 Fusen Pharmaceutical Business Overview
- 12.6.3 Fusen Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.6.4 Fusen Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
- 12.6.5 Fusen Pharmaceutical Recent Developments
- 12.7 Gerun Pharmaceutical
- 12.7.1 Gerun Pharmaceutical Company Information
- 12.7.2 Gerun Pharmaceutical Business Overview
- 12.7.3 Gerun Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.7.4 Gerun Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
- 12.7.5 Gerun Pharmaceutical Recent Developments
- 12.8 CR SANJIU
- 12.8.1 CR SANJIU Company Information
- 12.8.2 CR SANJIU Business Overview
- 12.8.3 CR SANJIU Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.8.4 CR SANJIU Antiviral Traditional Chinese Medicine Product Portfolio
- 12.8.5 CR SANJIU Recent Developments
- 12.9 Jumpcan
- 12.9.1 Jumpcan Company Information
- 12.9.2 Jumpcan Business Overview
- 12.9.3 Jumpcan Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.9.4 Jumpcan Antiviral Traditional Chinese Medicine Product Portfolio
- 12.9.5 Jumpcan Recent Developments
- 12.10 Qingfeng Pharmaceutical Group
- 12.10.1 Qingfeng Pharmaceutical Group Company Information
- 12.10.2 Qingfeng Pharmaceutical Group Business Overview
- 12.10.3 Qingfeng Pharmaceutical Group Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.10.4 Qingfeng Pharmaceutical Group Antiviral Traditional Chinese Medicine Product Portfolio
- 12.10.5 Qingfeng Pharmaceutical Group Recent Developments
- 12.11 Livzon
- 12.11.1 Livzon Company Information
- 12.11.2 Livzon Business Overview
- 12.11.3 Livzon Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.11.4 Livzon Antiviral Traditional Chinese Medicine Product Portfolio
- 12.11.5 Livzon Recent Developments
- 12.12 Green Valley Pharma
- 12.12.1 Green Valley Pharma Company Information
- 12.12.2 Green Valley Pharma Business Overview
- 12.12.3 Green Valley Pharma Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.12.4 Green Valley Pharma Antiviral Traditional Chinese Medicine Product Portfolio
- 12.12.5 Green Valley Pharma Recent Developments
- 12.13 Chase Sun Pharmaceutical
- 12.13.1 Chase Sun Pharmaceutical Company Information
- 12.13.2 Chase Sun Pharmaceutical Business Overview
- 12.13.3 Chase Sun Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.13.4 Chase Sun Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
- 12.13.5 Chase Sun Pharmaceutical Recent Developments
- 12.14 TASLY
- 12.14.1 TASLY Company Information
- 12.14.2 TASLY Business Overview
- 12.14.3 TASLY Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.14.4 TASLY Antiviral Traditional Chinese Medicine Product Portfolio
- 12.14.5 TASLY Recent Developments
- 12.15 Yusheng Pharmaceutical
- 12.15.1 Yusheng Pharmaceutical Company Information
- 12.15.2 Yusheng Pharmaceutical Business Overview
- 12.15.3 Yusheng Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.15.4 Yusheng Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
- 12.15.5 Yusheng Pharmaceutical Recent Developments
- 12.16 Tongrentang
- 12.16.1 Tongrentang Company Information
- 12.16.2 Tongrentang Business Overview
- 12.16.3 Tongrentang Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.16.4 Tongrentang Antiviral Traditional Chinese Medicine Product Portfolio
- 12.16.5 Tongrentang Recent Developments
- 12.17 Wuzhou Pharmaceutical
- 12.17.1 Wuzhou Pharmaceutical Company Information
- 12.17.2 Wuzhou Pharmaceutical Business Overview
- 12.17.3 Wuzhou Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.17.4 Wuzhou Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
- 12.17.5 Wuzhou Pharmaceutical Recent Developments
- 12.18 Yiling Pharmaceutical
- 12.18.1 Yiling Pharmaceutical Company Information
- 12.18.2 Yiling Pharmaceutical Business Overview
- 12.18.3 Yiling Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.18.4 Yiling Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
- 12.18.5 Yiling Pharmaceutical Recent Developments
- 12.19 Yunnan Baiyao
- 12.19.1 Yunnan Baiyao Company Information
- 12.19.2 Yunnan Baiyao Business Overview
- 12.19.3 Yunnan Baiyao Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.19.4 Yunnan Baiyao Antiviral Traditional Chinese Medicine Product Portfolio
- 12.19.5 Yunnan Baiyao Recent Developments
- 12.20 Changbaishan Pharmaceutical
- 12.20.1 Changbaishan Pharmaceutical Company Information
- 12.20.2 Changbaishan Pharmaceutical Business Overview
- 12.20.3 Changbaishan Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.20.4 Changbaishan Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
- 12.20.5 Changbaishan Pharmaceutical Recent Developments
- 12.21 Zhejiang Conba Pharmaceutical
- 12.21.1 Zhejiang Conba Pharmaceutical Company Information
- 12.21.2 Zhejiang Conba Pharmaceutical Business Overview
- 12.21.3 Zhejiang Conba Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.21.4 Zhejiang Conba Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
- 12.21.5 Zhejiang Conba Pharmaceutical Recent Developments
- 12.22 Zhejiang Kanglaite Pharmaceutical
- 12.22.1 Zhejiang Kanglaite Pharmaceutical Company Information
- 12.22.2 Zhejiang Kanglaite Pharmaceutical Business Overview
- 12.22.3 Zhejiang Kanglaite Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.22.4 Zhejiang Kanglaite Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
- 12.22.5 Zhejiang Kanglaite Pharmaceutical Recent Developments
- 12.23 ZBD Pharmaceutical
- 12.23.1 ZBD Pharmaceutical Company Information
- 12.23.2 ZBD Pharmaceutical Business Overview
- 12.23.3 ZBD Pharmaceutical Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.23.4 ZBD Pharmaceutical Antiviral Traditional Chinese Medicine Product Portfolio
- 12.23.5 ZBD Pharmaceutical Recent Developments
- 12.24 China TCM
- 12.24.1 China TCM Company Information
- 12.24.2 China TCM Business Overview
- 12.24.3 China TCM Revenue in Antiviral Traditional Chinese Medicine Business (2021-2026)
- 12.24.4 China TCM Antiviral Traditional Chinese Medicine Product Portfolio
- 12.24.5 China TCM Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst